Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.

Front Immunol · 2021 · PMC8187869 · PMID 34122439

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP ≤ 3.42 x 10 -8actually significant

In fingolimod-treated patients, the decrease in BAFF-R expression was highly significant in all evaluated B cell subsets (1.77 x 10 -5 ≤ P ≤ 3.42 x 10 -8 ) and most manifest in terms of effect size on transitional B cells ( Figures 2A–D ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.